aod9604 stimulates lipolysis adipocytes AOD-9604 5mg – Neurovia AOD9604 - Research Peptide -
Description
While higher doses (particularly 54 mg) showed some increase in gastrointestinal-related events, these remained mild to moderate in severity and did not result in treatment discontinuation
These symptoms occur because the body struggles to produce enough red blood cells
[DOI] [PMC free article] [PubMed] [Google Scholar] 90.Bi HC, et al
Note that a small amount of medication may release as well
And understanding how supplements affect your skin is part of empowering you to make informed decisions
